Company page

Novo Nordisk A/s Class B

Novo Nordisk A/S Class B is a leading pharmaceutical company based in Denmark, specializing in diabetes care and hormone replacement therapies. With a market capitalization of approximately 190.45 billion DKK, the company is recognized for its innovative approach to healthcare solutions. Novo Nordisk is committed to improving the lives of patients through its extensive portfolio of medications and treatments.